These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

340 related articles for article (PubMed ID: 33313997)

  • 1. Molecular probes for the human adenosine receptors.
    Yang X; Heitman LH; IJzerman AP; van der Es D
    Purinergic Signal; 2021 Mar; 17(1):85-108. PubMed ID: 33313997
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemical Probes for the Adenosine Receptors.
    Federico S; Lassiani L; Spalluto G
    Pharmaceuticals (Basel); 2019 Nov; 12(4):. PubMed ID: 31726680
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure-based approaches to ligands for G-protein-coupled adenosine and P2Y receptors, from small molecules to nanoconjugates.
    Jacobson KA
    J Med Chem; 2013 May; 56(10):3749-67. PubMed ID: 23597047
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fluorescent ligands for adenosine receptors.
    Kozma E; Jayasekara PS; Squarcialupi L; Paoletta S; Moro S; Federico S; Spalluto G; Jacobson KA
    Bioorg Med Chem Lett; 2013 Jan; 23(1):26-36. PubMed ID: 23200243
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Purinergic receptors modulators: An emerging pharmacological tool for disease management.
    Mahmood A; Iqbal J
    Med Res Rev; 2022 Jul; 42(4):1661-1703. PubMed ID: 35561109
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Covalent molecular probes for class A G protein-coupled receptors: advances and applications.
    Weichert D; Gmeiner P
    ACS Chem Biol; 2015 Jun; 10(6):1376-86. PubMed ID: 25860503
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Allosteric modulators for adenosine receptors: an alternative to the orthosteric ligands.
    La Motta C; Sartini S; Morelli M; Taliani S; Da Settimo F
    Curr Top Med Chem; 2010; 10(10):976-92. PubMed ID: 20370657
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New heterocyclic ligands for the adenosine receptors P1 and for the ATP receptors P2.
    Baraldi PG; Romagnoli R; Tabrizi MA; Bovero A; Preti D; Fruttarolo F; Moorman AR; Borea PA
    Farmaco; 2005 Mar; 60(3):185-202. PubMed ID: 15784237
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular Dynamics Simulations of Adenosine Receptors: Advances, Applications and Trends.
    Al-Shar'i NA; Al-Balas QA
    Curr Pharm Des; 2019; 25(7):783-816. PubMed ID: 30834825
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New paradigms in adenosine receptor pharmacology: allostery, oligomerization and biased agonism.
    Vecchio EA; Baltos JA; Nguyen ATN; Christopoulos A; White PJ; May LT
    Br J Pharmacol; 2018 Nov; 175(21):4036-4046. PubMed ID: 29679502
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fluorescent probes for G-protein-coupled receptor drug discovery.
    Iliopoulos-Tsoutsouvas C; Kulkarni RN; Makriyannis A; Nikas SP
    Expert Opin Drug Discov; 2018 Oct; 13(10):933-947. PubMed ID: 30249143
    [TBL] [Abstract][Full Text] [Related]  

  • 12. G protein-coupled receptors expressed and studied in yeast. The adenosine receptor as a prime example.
    Wang X; van Westen GJP; Heitman LH; IJzerman AP
    Biochem Pharmacol; 2021 May; 187():114370. PubMed ID: 33338473
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Allosteric modulation of adenosine receptors.
    Göblyös A; Ijzerman AP
    Biochim Biophys Acta; 2011 May; 1808(5):1309-18. PubMed ID: 20599682
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biased agonism at adenosine receptors.
    McNeill SM; Baltos JA; White PJ; May LT
    Cell Signal; 2021 Jun; 82():109954. PubMed ID: 33610717
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 7-Nitrobenzofurazan (NBD) derivatives of 5'-N-ethylcarboxamidoadenosine (NECA) as new fluorescent probes for human A(3) adenosine receptors.
    Macchia M; Salvetti F; Bertini S; Di Bussolo V; Gattuso L; Gesi M; Hamdan M; Klotz KN; Laragione T; Lucacchini A; Minutolo F; Nencetti S; Papi C; Tuscano D; Martini C
    Bioorg Med Chem Lett; 2001 Dec; 11(23):3023-6. PubMed ID: 11714602
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting Adenosine Receptors: A Potential Pharmacological Avenue for Acute and Chronic Pain.
    Vincenzi F; Pasquini S; Borea PA; Varani K
    Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33218074
    [TBL] [Abstract][Full Text] [Related]  

  • 17. G protein-coupled adenosine (P1) and P2Y receptors: ligand design and receptor interactions.
    Jacobson KA; Balasubramanian R; Deflorian F; Gao ZG
    Purinergic Signal; 2012 Sep; 8(3):419-36. PubMed ID: 22371149
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacophoric models and 3D QSAR studies of the adenosine receptor ligands.
    Tintori C; Manetti F; Botta M
    Curr Top Med Chem; 2010; 10(10):1019-35. PubMed ID: 20370655
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PET Imaging of Adenosine Receptors in Diseases.
    Li J; Hong X; Li G; Conti PS; Zhang X; Chen K
    Curr Top Med Chem; 2019; 19(16):1445-1463. PubMed ID: 31284861
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The structure of the adenosine receptors: implications for drug discovery.
    Lane JR; Jaakola VP; Ijzerman AP
    Adv Pharmacol; 2011; 61():1-40. PubMed ID: 21586354
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.